Adrenal myelolipoma is a rare tumor that is benign in nature, usually asymptomatic, unilateral, and nonsecreting. It is composed of variable mixture of mature adipose tissue and hematopoietic elements and develops within the adrenal gland. With the widespread use of cross-sectional imaging modalities such as ultrasonography (USG) and computed tomography (CT), the incidental detection of these tumors is increasing in frequency. We report two cases of adrenal myelolipoma in a 48-year-old female and a 47-year old male who presented with pain in the abdomen. Contrast-enhanced computed tomography scan of the abdomen revealed the possibility of myelolipoma. The patients were subjected to adrenalectomy and their postoperative course was uneventful. The histopathological evaluation of the mass confirmed the initial diagnosis of adrenal myelolipoma. Although mostly discovered as an "incidentaloma," the diagnosis of adrenal myelolipoma requires thorough diagnostic study. Imaging techniques such as USG and CT scans as well as biochemical studies are useful for indicating the best treatment taking into account the size of the mass and possible hormone production. Surgical resection is advocated through extraperitoneal approach as it minimizes postoperative complications and leads to quicker recovery.
INTRODUCTION
Adrenal myelolipoma is a rare urological lesion and is usually benign in nature. It is composed of mixture of mature adipose and hematopoietic elements. It was first described by Gierke in 1905 and later on termed as "myelolipoma" by Oberling in 1929. [1] Earlier, these lesions were detected at autopsy or in conditions where massive growth or an alteration in the hormonal production led to clinical presentation. However, nowadays, with the widespread use of noninvasive cross-sectional imaging modalities such as ultrasonography (USG), computed tomography (CT), and magnetic resonance imaging, incidental detection is more common. [2] Hence, it is also known as "incidentalomas." Men and women are equally affected, and it is most commonly found between the fifth and seventh decades of life. They are usually nonsecreting, but overproduction of adrenal hormones is also described in some cases. [3] Here, we describe two cases of incidental diagnosis of a large adrenal myelolipoma in patients who presented with upper abdominal pain and review the literature on its etiology, diagnosis, and management.
CASE REPORT

Case 1
A 48-year-old female presented with complaints of dull aching, intermittent, nonradiating abdominal pain since 20 days and also had history of hypertension. On physical examination, a lump was felt in the right lumbar fossa which was around 8 × 8 cm. The skin over the abdomen was normal and all the quadrants moved equally with respiration. Initial laboratory data including hemogram and biochemical analysis were within normal limit. Endocrinological tests and assay of urinary catecholamines did not show significant alterations. USG showed the presence of a hyperechoic mass with non-well-defined boundaries in the right suprarenal region. Contrast-enhanced computed tomography (CECT) revealed large well-defined soft-tissue density lesion involving right suprarenal location measuring 11 × 8 cm showing significant fat density, causing mass effect in the form of compression of posteroinferior surface of the liver anteriorly and abutting the right crus of the diaphragm posteriorly, likely to be adrenal myelolipoma [ Figure 1a ].
Case 2
A 47-year-old male presented with dull-aching pain in the right flank region since 2 years which has been increased since the past 4 months. Pain was radiating to the right lumbar region and continuous in nature. History of burning micturition and urgency was present. On examination, there was no palpable lump. Mild tenderness was present in the lumbar region. Free metanephrine level was 77.0 pg/mL. USG showed the features suggestive of right-side multiloculated cystic lesion Bosniak type IIF/chronic focal hydronephrosis. CECT revealed multiloculated cystic lesion in the lower pole of the right kidney and heterogeneous fat-containing lesion measuring 6.4 × 4.7 × 3.3 cm in the left adrenal gland, suggesting the possibility of adrenal myelolipoma [ Figure 1b ].
After a thorough preoperative workup, surgical right adrenalectomy was performed for both the patients through right subcostal incision for extraperitoneal approach of the adrenal gland. The masses were totally dissected from the upper pole of the kidney and sent for histopathological evaluation. Gross examination of the specimens revealed large, round, 11 × 9× 4.5 cm [ Figure 2a ] and 6.5 × 5× 2.5 cm encapsulated masses with smooth external surface weighing 675 and 384 g, respectively. The cut surface of both revealed a solid tumor with a variegated appearance of dark brown and yellowish areas [ Figure 2b ]. Microscopy showed a characteristic admixture of mature adipocytes and hematopoietic elements [ Figure 3a ]. A thin rim of normal adrenal parenchyma with capsule was also identified at the periphery [ Figure 3b ], thus confirming the diagnosis of adrenal myelolipoma. Patients' postoperative course was totally uneventful. 
DISCUSSION
Myelolipoma of the adrenal gland is a rare, benign, and biochemically inactive tumor comprising variable proportions of mature fat and hematopoietic elements. Their diagnosis is usually based on autopsy or imaging modalities which are performed for other reasons that are unrelated to adrenal diseases. The incidence ranges from 0.08% to 0.4%. [1, 4, 5] However, their prevalence appears to be increasing up to 15%, due to the recent advances in noninvasive and enhanced imaging techniques. [6] These lesions are mostly seen in the fifth to seventh decades and are usually unilateral and asymptomatic. [6, 7] However, few bilateral tumors have also been described. Myelolipomas are often smaller than 4 cm in diameter, but can reach variable sizes. The largest adrenal myelolipoma reported in the literature weighed 6 kg and measured 31 × 24.5 × 11.5 cm. These lesions generally do not recur after surgical resection. [3, 8] Adrenal gland is predominantly involved, but extra-adrenal presentations have also been reported in presacral area, stomach, liver, lymph nodes, mediastinum, and cranium. [9, 10] Approximately 36 extraadrenal myelolipomas have been described in English literature. [11] Their histogenesis is still uncertain, but different theories have been proposed, such as the development from stem cell rests, embolism of bone marrow cells, and extramedullary hematopoiesis. The most widely accepted theory is that by Meaglia and Schmidt, in 1992, which affirms that myelolipomas arise due to metaplasia of reticuloendothelial cells of blood capillaries in the adrenal gland in response to stimuli, such as chronic stress, infection, necrosis, or inflammation. [1, 10] Other contemporary authors have speculated about a stressful lifestyle and an unbalanced diet as factors that may be involved in the pathogenesis of this tumor. [3] Frequent association with obesity, type 2 diabetes mellitus, and arterial hypertension was observed. [4, 10] Most myelolipomas are asymptomatic but when the tumors grow large, they may cause compressive symptoms, tumor necrosis, or hemorrhage and present with abdominal and flank pain, palpable mass, or hematuria. Though usually nonfunctional, 10% are associated with endocrine conditions such as Conn's syndrome, Cushing's disease, and diabetes. There is no potential for malignancy. [4, 9] CT is the preferred primary modality for evaluation which in most cases is done for some other reason. A majority of adrenal myelolipomas are composed of fat tissue, which has a negative HU value. The CT values are usually higher than those of retroperitoneal fat (typically measuring less than -20 HU) owing to the associated hematopoietic tissue component. [2, 9] If adrenal myelolipoma becomes larger, the differential diagnosis should include lipoma and liposarcoma. [1, 5, 9] The possibility could be low because these tumors rarely occur in adrenal gland, but sometimes percutaneous biopsy may be necessary to confirm the diagnosis. [9] The macroscopic analysis shows adipose yellow tissue with rare areas of hemorrhage and residual adrenal tissue. Myelolipomas are generally surrounded by a fine fibrous capsule and displace adjacent structures. [10] The microscopic examination reveals mature adipose tissue along with islands of elements of the three hematopoietic lineages with no maturation abnormalities.
In our cases, the macroscopic and microscopic findings were characteristic of myelolipoma. Lipoblasts, atypical adipocytes, mitotic activity, cellular pleomorphism, and necrosis were not noted. The residual adrenal tissue at the periphery of the lesion was composed of typical and uniform adrenal cortical cells.
Management of adrenal myelolipoma should be considered on individual basis. Small lesions, which are asymptomatic and less than 5 cm, should be monitored for 1-2 years with imaging controls. [1] Symptomatic tumors or myelolipomas larger than 5 cm should be surgically excised, so as to prevent an emergency because of spontaneous rupture and hemorrhage of the mass presented with life-threatening cardiovascular shock. [4, 10] In cases such as ours, extraperitoneal approach is preferable than midline incision as it leads to quicker recovery of the patient and lesser postoperative complications.
CONCLUSION
Although mostly discovered as an "incidentaloma," the diagnosis of adrenal myelolipoma requires thorough diagnostic study. Imaging techniques such as USG and CT scans and biochemical studies are useful for deciding the best treatment depending on the size of the mass and hormone production. Surgical resection is advocated through extraperitoneal approach as it minimizes postoperative complications and leads to quicker recovery.
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